Fallopian Tube Cancer Clinical Trials in Aurora, Colorado

3 studies are recruiting for fallopian tube cancer in Aurora, Colorado right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Cirtuvivint/Olaparib in Breast Cancer Susceptibility Gene/Homologous Recombination Deficiency Platinum Resistant Ovarian Cancer

    The purpose of this study is to learn about the safety and tolerability of Cirtuvivint in combination with Olaparib in platinum resistant ovarian cancer. The study also aims to determine the recommended dose of the combination therapy. If a participant is a good fit for the study, and they enroll i…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    CU Medicine Clinics, Aurora, Colorado
    Locations
    2 in total
    Run by
    University of Colorado, Denver

    See if you can join NCT06856499 on ClinicalTrials.gov

  2. An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

    The Principal Investigator hypothesizes the combination of MIRV and Olaparib is an effective, and tolerable, maintenance therapy strategy in platinum sensitive recurrent ovarian cancer.

    Stage
    Phase 2
    Ages
    18 to 100
    Site
    University of Colorado Hospital, Aurora, Colorado
    Locations
    6 in total
    Run by
    University of Colorado, Denver

    See if you can join NCT05887609 on ClinicalTrials.gov

  3. A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer

    This is a Phase 1b open-label, multicenter study, evaluating the safety, tolerability, preliminary clinical activity, pharmacokinetics (PK), and pharmacodynamics of azenosertib (ZN-c3) in combination with other drugs.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Site 0264, Aurora, Colorado
    Locations
    24 in total
    Run by
    K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

    See if you can join NCT04516447 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.